ICVDV
Desconocido
SILICOFCM: In Silico trials for drug tracing the effects of sarcomeric protein mutations leading to familial ca...
INSTITUT ZA KARDIOVASKULARNE BOLESTI VOJVODINE
participó en un
H2020:
H2020-SC1-2016-2017
According to the 2014 European Society of Cardiology Guidelines, cardiomyopathies are defined as structural and functional abnormalities of...
2018-05-08 - 2022-02-28 | Financiado
2018-05-08 - 2022-02-28 | Financiado
DISCHARGE: Diagnostic Imaging Strategies for Patients with Stable Chest Pain and Intermediate Risk of Coronary...
INSTITUT ZA KARDIOVASKULARNE BOLESTI VOJVODINE
participó en un
FP7:
Coronary artery disease (CAD) is the leading cause of death in high-income countries. Invasive coronary angiography (ICA) is the reference s...
Financiado
Financiado
* No se disponen de datos de la empresa actual.